Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family

• References

• 1 Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001; 109: 369-84.
• 2 Souto JC, Almasy L, Borrelll M. et al Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Am J Hum Genet 2000; 67: 1452-59
• 3 De Stefano V, Martinelli I, Mannucci PM. et al The risk of recurrent deep venous thrombosis among heterozygous carriers of both Factor V Leiden and the G20210A Prothrombin mutation. N Engl J Med 1999; 341: 801-6
• 4 Soria JM, Almasy L, Souto JC. et al A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility. Blood 2003; Jan 1 101 (01) 163-7.
• 5 Makris M, Preston F, Beauchamp N. et al Co-inheritance of the 20210 A allele of the prothrombin gene increase the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426-9
• 6 Ehrenforth S, Ludwing G, Klinke S. et al The prothrombin 20210A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood 1998; 91: 2209-10
• 7 Zöller B, Svensson PJ, Dahlbäck B. et al The A20210 allele of the prothrombin gene is frequently as- sociated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood 1998; 91: 2210-1
• 8 Soria JM, Almasy L, Souto JC. et al A quantitativetrait locus in human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 2002; 70: 567-74
• 9 Tirado I, Soria JM, Mateo J. et al Association after linkage analysis indicates that homozygosity for the 46CàT polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004; 91: 899-904
• 10 Garcia A, Calabuig M, Santamaría A. et al Complexity of the genetic contribution of different thrombotic risk factors in a Spanish thrombophilic family. Thromb Haemost (In press 2005).
• 11 Williamson D, Brown K, Luddington R. et al Factor V Cambridge: A new mutation (Arg ³⁰⁶®Thr) associated with resistance to activated protein C. Blood 1998; 91 (04) 1140-4.
• 12 Franco R, Maffei F, Lourenco D. et al Factor V Arg ³⁰⁶®Thr (Factor V Cambridge) and Factor V V Arg ³⁰⁶®Gly mutations in venous thrombotic disease. Br J Haematol 1998; 103: 888-90
• 13 Nortrom E, Thorelli E, Dahlbäck B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 2002; 100: 524-30
• 14 Franco R, Elion J, Tavella M. et al The prevalence of Factor V Arg³⁰⁶®Thr (Factor V Cambridge) and Factor V Arg³⁰⁶®Gly mutations in different Human populations. Thromb Haemost 1999; 81: 312-3
• 15 Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-51